Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

TEJAS PATIL

Allopathic & Osteopathic Physicians Hospitalist

NPI
1336482769
CMS profile
4326615
Location
AURORA, CO

General Payments · PY2018–2024

$55,161.66

  • Reported across 72 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$21,512.31

34 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $221.83 2
PY2019 $343.26 4
PY2020 $1,278.43 3
PY2021 $6,078.59 5
PY2022 $3,805.87 7
PY2023 $21,921.37 17
PY2024 $21,512.31 34

Payment records · PY2024 (34)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Aadi Bioscience, Inc. $685.00 09/27/2024 Consulting Fee Undisputed 01/23/2026 1119596413 CMS
AstraZeneca Pharmaceuticals LP $57.44 09/07/2024 Food and Beverage Undisputed 01/23/2026 1104343626 CMS
AstraZeneca Pharmaceuticals LP $1,110.00 11/07/2024 Consulting Fee Undisputed 01/23/2026 1105592280 CMS
E.R. Squibb & Sons, L.L.C. $2,175.00 01/16/2024 Consulting Fee Undisputed 01/23/2026 1101547612 CMS
E.R. Squibb & Sons, L.L.C. $55.52 11/07/2024 Food and Beverage Undisputed 01/23/2026 1101547766 CMS
E.R. Squibb & Sons, L.L.C. $25.45 11/07/2024 Food and Beverage Undisputed 01/23/2026 1101547770 CMS
E.R. Squibb & Sons, L.L.C. $42.80 11/07/2024 Food and Beverage Undisputed 01/23/2026 1101547774 CMS
E.R. Squibb & Sons, L.L.C. $3,600.00 12/11/2024 Consulting Fee Undisputed 01/23/2026 1101547748 CMS
Genentech USA, Inc. $77.91 09/09/2024 Food and Beverage Undisputed 01/23/2026 1133122610 CMS
Janssen Biotech, Inc. $68.96 09/06/2024 Food and Beverage Undisputed 01/23/2026 1078358678 CMS
Janssen Biotech, Inc. $1,293.75 10/11/2024 Consulting Fee Undisputed 01/23/2026 1078358948 CMS
Janssen Scientific Affairs, LLC $29.59 01/05/2024 Food and Beverage Undisputed 01/23/2026 1078846187 CMS
Janssen Scientific Affairs, LLC $37.20 04/09/2024 Food and Beverage Undisputed 01/23/2026 1078846195 CMS
Janssen Scientific Affairs, LLC $104.87 06/02/2024 Food and Beverage Undisputed 01/23/2026 1078846227 CMS
Janssen Scientific Affairs, LLC $90.86 09/08/2024 Food and Beverage Undisputed 01/23/2026 1078846223 CMS
JAZZ PHARMACEUTICALS INC. $38.41 06/02/2024 Food and Beverage Undisputed 01/23/2026 1150210451 CMS
Partner Therapeutics, Inc. $52.43 12/12/2024 Food and Beverage Undisputed 01/23/2026 1141328800 CMS
Partner Therapeutics, Inc. $150.00 12/12/2024 Food and Beverage Undisputed 01/23/2026 1141328804 CMS
Partner Therapeutics, Inc. $293.08 12/12/2024 Travel and Lodging Undisputed 01/23/2026 1141328944 CMS
Partner Therapeutics, Inc. $307.23 12/12/2024 Travel and Lodging Undisputed 01/23/2026 1141328966 CMS
Partner Therapeutics, Inc. $48.29 12/13/2024 Food and Beverage Undisputed 01/23/2026 1141328824 CMS
Partner Therapeutics, Inc. $49.99 12/13/2024 Food and Beverage Undisputed 01/23/2026 1141328854 CMS
Partner Therapeutics, Inc. $24.99 12/13/2024 Food and Beverage Undisputed 01/23/2026 1141328884 CMS
Partner Therapeutics, Inc. $65.00 12/13/2024 Food and Beverage Undisputed 01/23/2026 1141328914 CMS
PFIZER INC. $115.59 06/02/2024 Food and Beverage Undisputed 01/23/2026 1131585526 CMS
PFIZER INC. $1,440.00 08/13/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1130953627 CMS
PFIZER INC. $1,440.00 08/21/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1131426223 CMS
Takeda Pharmaceuticals U.S.A., Inc. $6,885.00 04/02/2024 Consulting Fee Undisputed 01/23/2026 1144964975 CMS
Takeda Pharmaceuticals U.S.A., Inc. $264.44 04/02/2024 Travel and Lodging Undisputed 01/23/2026 1144964977 CMS
Takeda Pharmaceuticals U.S.A., Inc. $214.40 04/02/2024 Travel and Lodging Undisputed 01/23/2026 1144964979 CMS
Takeda Pharmaceuticals U.S.A., Inc. $529.69 04/02/2024 Travel and Lodging Undisputed 01/23/2026 1144964981 CMS
Takeda Pharmaceuticals U.S.A., Inc. $55.92 04/02/2024 Food and Beverage Undisputed 01/23/2026 1144964983 CMS
Takeda Pharmaceuticals U.S.A., Inc. $36.00 04/02/2024 Travel and Lodging Undisputed 01/23/2026 1144964985 CMS
Takeda Pharmaceuticals U.S.A., Inc. $47.50 05/09/2024 Food and Beverage Undisputed 01/23/2026 1144964987 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.